Delcath Systems Inc (DCTH)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Delcath Systems Inc (DCTH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013819
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Delcath Systems Inc (Delcath) is a specialty pharmaceutical and medical device company, which specializes in developing percutaneous perfusion technologies to treat primary and metastatic liver cancers. Its patented drug delivery platform delivers ultra-high doses of anti-cancer drugs to the liver, while preventing them from entering the patient’s bloodstream. Delcath’s proprietary product, Melphalan Hydrochloride for injection is being developed for use with the Delcath Hepatic Delivery System (Melphalan/HDS) and to administer high dose chemotherapy to the liver. The company sells its proprietary system to deliver and filter melphalan hydrochloride in Europe under the trade name, Delcath Hepatic Chemosat Delivery System for Melphalan (Chemosat). Delcath is headquartered in New York, the US.

Delcath Systems Inc (DCTH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Delcath Systems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Delcath Systems Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Delcath Systems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Delcath Systems Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Delcath Systems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Delcath Systems Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Delcath Systems Files Registration Statement for Public Offering of Units for USD17.3 Million 10
Delcath Systems to Raise USD2.4 Million in Private Placement of Series B Preferred Shares 11
Delcath Systems Raises USD1.3 Million in Public Offering Shares and Warrants 12
Delcath Systems Raises USD7 Million in Public Offering of Units 13
Delcath Systems Raises USD3 Million in Public Offering of Shares and Warrants 15
Delcath Systems to Raise Additional USD6 Million in Public Offering of Shares 17
Delcath Systems Completes Public Offering Of Shares For US$7.5 Million 18
Delcath Systems Completes Private Placement Of Shares For US$2 Million 19
Delcath Systems Completes Public Offering Of Units For US$23 Million 20
Delcath Systems Completes Second Tranche Of Private Placement Of Shares For US$1.2 Million 21
Delcath Systems Files Registration Statement For Public Offering Of Securities For US$100 Million 23
Delcath Systems Completes Public Offering Of Common Stock For US$25.3 Million 24
Delcath Systems Inc – Key Competitors 25
Delcath Systems Inc – Key Employees 26
Delcath Systems Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Nov 14, 2017: Delcath Announces Third Quarter 2017 Financial Results 28
Aug 08, 2017: Delcath Announces Second Quarter 2017 Financial Results 30
May 09, 2017: Delcath Announces First Quarter 2017 Financial Results 32
Mar 29, 2017: Delcath Announces 2016 Financial Results 34
Aug 16, 2016: Delcath Announces Second Quarter Financial Results 36
May 04, 2016: Delcath Announces First Quarter Financial Results 38
Mar 21, 2016: Delcath Announces 2015 Fourth Quarter and Full Year Financial Results 39
Corporate Communications 41
Feb 11, 2016: Delcath announces Engagement of Lars E. Birgerson, M.D., Ph. D as global medical consultant 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Delcath Systems Inc, Medical Equipment, Key Facts, 2016 2
Delcath Systems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Delcath Systems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Delcath Systems Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Delcath Systems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Delcath Systems Inc, Deals By Market, 2011 to YTD 2017 8
Delcath Systems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Delcath Systems Files Registration Statement for Public Offering of Units for USD17.3 Million 10
Delcath Systems to Raise USD2.4 Million in Private Placement of Series B Preferred Shares 11
Delcath Systems Raises USD1.3 Million in Public Offering Shares and Warrants 12
Delcath Systems Raises USD7 Million in Public Offering of Units 13
Delcath Systems Raises USD3 Million in Public Offering of Shares and Warrants 15
Delcath Systems to Raise Additional USD6 Million in Public Offering of Shares 17
Delcath Systems Completes Public Offering Of Shares For US$7.5 Million 18
Delcath Systems Completes Private Placement Of Shares For US$2 Million 19
Delcath Systems Completes Public Offering Of Units For US$23 Million 20
Delcath Systems Completes Second Tranche Of Private Placement Of Shares For US$1.2 Million 21
Delcath Systems Files Registration Statement For Public Offering Of Securities For US$100 Million 23
Delcath Systems Completes Public Offering Of Common Stock For US$25.3 Million 24
Delcath Systems Inc, Key Competitors 25
Delcath Systems Inc, Key Employees 26
Delcath Systems Inc, Other Locations 27
Delcath Systems Inc, Subsidiaries 27

★海外企業調査レポート[Delcath Systems Inc (DCTH)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NIIT Ltd (NIITLTD):企業の財務・戦略的SWOT分析
    NIIT Ltd (NIITLTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • PENTAX Medical Co:医療機器:M&Aディール及び事業提携情報
    Summary Pentax Medical Co (Pentax Medical), a subsidiary of Pentax of America Inc, is a medical device company that offers endoscopic products and services. The company offers products such as colonoscopes, sigmoidscopes, echoendoscopes, small bowel enteroscope, duodenoscopes, choledochoscope, advan …
  • Swiss Life Holding Ltd:企業のM&A・事業提携・投資動向
    Swiss Life Holding Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swiss Life Holding Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Actinium Pharmaceuticals Inc (ATNM):企業の財務・戦略的SWOT分析
    Summary Actinium Pharmaceuticals Inc (Actinium), formerly Cactus Ventures Inc, is a biopharmaceutical company. It develops antibody radiation conjugates (ARC), which combine the targeting ability of antibodies with the cell killing ability of radiation. The company's pipeline products include Iomab- …
  • Swiss Life Holding Ltd:企業の戦略・SWOT・財務情報
    Swiss Life Holding Ltd - Strategy, SWOT and Corporate Finance Report Summary Swiss Life Holding Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ERM Power Ltd:企業の戦略的SWOT分析
    ERM Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Eyevensys SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Eyevensys SAS (Eyevensys) is a clinical stage biotechnology company developing non-viral gene therapies for ophthalmic diseases. Its lead product, EYS-606, is a soluble TNFa receptor plasmid associated with the ETIS device to treat non-infectious intermediate and posterior uveitis(NIU); EYS- …
  • Tamilnadu Petroproducts Ltd (TNPETRO):企業の財務・戦略的SWOT分析
    Summary Tamilnadu Petroproducts Ltd (TPL), a subsidiary of Southern Petrochemical Industries Corp Ltd is a petrochemical company that manufactures and markets petrochemical and related products. The company offers products such as chlorine, heavy chemicals, heavy alkylate, linear alkyl benzene, ammo …
  • Biodesy Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Biodesy Inc (Biodesy) is a drug discovery company that develops and offers products for detecting conformational change in proteins and other biological molecules. The company provides products such as delta system, delta assay and screening kits, and delta software, among others. It also de …
  • Mapletree Investments Pte Ltd:企業の戦略的SWOT分析
    Mapletree Investments Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Calithera Biosciences Inc (CALA):企業の財務・戦略的SWOT分析
    Summary Calithera Biosciences Inc (Calithera) is a clinical-stage bio-pharmaceutical company that discovers and develops novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer . The company’s product pipeline includes CB-839, a glutamina …
  • Venado Oil & Gas LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Venado Oil & Gas LLC (Venado) is an oil and gas company that offers oil and gas services. The company explores and develops oil and natural gas properties in the Gulf Coast and Permian regions of Texas. It also provides crude oil and natural gas products. Venado offers services such as execu …
  • Drone Aviation Holding Corp (DRNE):企業の財務・戦略的SWOT分析
    Summary Drone Aviation Holding Corp (Drone) operates as a technology company that develops, designs, markets and sells tethered drones, lighter-than-air advanced aerostats, and land-based intelligence, surveillance and reconnaissance solutions. The company’s products include drones, aerostat and mob …
  • Orange SA (ORA):企業の財務・戦略的SWOT分析
    Orange SA (ORA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Demant AS (DEMANT):企業の財務・戦略的SWOT分析
    Demant AS (DEMANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Key Energy Services, Inc. (KEG)-石油・ガス分野:企業M&A・提携分析
    Summary Key Energy Services, Inc. (Key) is an onshore, rig-based well servicing contractor, which offers a range of rig services. Its service line includes rig-based and coiled tubing-based well maintenance and workover services, well completion and recompletion services, fluid management services, …
  • Stage Stores Inc:戦略・SWOT・企業財務分析
    Stage Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Stage Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Provimi Holding BV:企業の戦略・SWOT・財務分析
    Provimi Holding BV - Strategy, SWOT and Corporate Finance Report Summary Provimi Holding BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Krka dd Novo Mesto (KRKG):企業の財務・戦略的SWOT分析
    Summary Krka dd Novo Mesto (Krka) is a manufacturer and distributor of pharmaceutical products. The company provides prescription pharmaceuticals, non-prescription products, and animal health products. It offers prescription products for cardiovascular diseases, diseases of alimentary tract and meta …
  • Tokyu Corporation:企業の戦略・SWOT・財務情報
    Tokyu Corporation - Strategy, SWOT and Corporate Finance Report Summary Tokyu Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆